| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $419.5M | +26.9% |
| Cost of Revenue | $108.8M | +31.8% |
| Gross Profit | $310.7M | +25.3% |
| R&D Expense | $52.6M | +8.0% |
| SG&A Expense | $81.0M | +17.1% |
| Operating Income | $33.0M | +361.0% |
| Pre-tax Income | $40.5M | +266.0% |
| Income Tax | $5.4M | +13.5% |
| Net Income | $34.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $481.1M | +65.5% |
| Accounts Receivable | $124.5M | +42.5% |
| Current Assets | $625.3M | +58.4% |
| Total Assets | $789.2M | +52.0% |
| Current Liabilities | $273.7M | +22.8% |
| Total Liabilities | $310.5M | +25.1% |
| Stockholders' Equity | $478.7M | +76.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $85.3M | -4.1% |
| Capital Expenditures | $3.7M | +21.0% |
| Investing Cash Flow | -$20.2M | -676.6% |
| Financing Cash Flow | $124.0M | +898.0% |
| Free Cash Flow | $81.6M | -5.0% |
| +219.6% |
| EPS (Basic) | $0.17 | +206.3% |
| EPS (Diluted) | $0.15 | +193.8% |